Found: 13
Select item for more details and to access through your institution.
MLIP causes recessive myopathy with rhabdomyolysis, myalgia and baseline elevated serum creatine kinase.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Spinal muscular atrophy care in the COVID-19 pandemic era.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Medical management of muscle weakness in Duchenne muscular dystrophy.
- Published in:
- PLoS ONE, 2020, v. 15, n. 10, p. 1, doi. 10.1371/journal.pone.0240687
- By:
- Publication type:
- Article
Pamrevlumab, a Fully Human Monoclonal Antibody Targeting Connective Tissue Growth Factor, for Non-Ambulatory Patients with Duchenne Muscular Dystrophy.
- Published in:
- Journal of Neuromuscular Diseases, 2023, v. 10, n. 4, p. 685, doi. 10.3233/JND-230019
- By:
- Publication type:
- Article
Intrathecal Onasemnogene Abeparvovec for Sitting, Nonambulatory Patients with Spinal Muscular Atrophy: Phase I Ascending-Dose Study (STRONG).
- Published in:
- Journal of Neuromuscular Diseases, 2023, v. 10, n. 3, p. 389, doi. 10.3233/JND-221560
- By:
- Publication type:
- Article
Clinical importance of changes in magnetic resonance biomarkers for Duchenne muscular dystrophy.
- Published in:
- Annals of Clinical & Translational Neurology, 2024, v. 11, n. 1, p. 67, doi. 10.1002/acn3.51933
- By:
- Publication type:
- Article
A comprehensive study of skeletal muscle imaging in FHL1‐related reducing body myopathy.
- Published in:
- Annals of Clinical & Translational Neurology, 2023, v. 10, n. 8, p. 1442, doi. 10.1002/acn3.51834
- By:
- Publication type:
- Article
Quantitative magnetic resonance imaging measures as biomarkers of disease progression in boys with Duchenne muscular dystrophy: a phase 2 trial of domagrozumab.
- Published in:
- Journal of Neurology, 2022, v. 269, n. 8, p. 4421, doi. 10.1007/s00415-022-11084-0
- By:
- Publication type:
- Article
Thoracoscopic thymectomy for juvenile myasthenia gravis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Ethical Challenges Confronted When Providing Nusinersen Treatment for Spinal Muscular Atrophy.
- Published in:
- JAMA Pediatrics, 2018, v. 172, n. 2, p. 188, doi. 10.1001/jamapediatrics.2017.4409
- By:
- Publication type:
- Article
Health Care Use of Cardiac Specialty Care in Children With Muscular Dystrophy in the United States.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Novel approaches to analysis of the North Star Ambulatory Assessment (NSAA) in Duchenne muscular dystrophy (DMD): Observations from a phase 2 trial.
- Published in:
- PLoS ONE, 2022, v. 17, n. 8, p. 1, doi. 10.1371/journal.pone.0272858
- By:
- Publication type:
- Article
In Vivo NADH Fluorescence Monitoring as an Assay for Cellular Damage in Photodynamic Therapy.
- Published in:
- Photochemistry & Photobiology, 2001, v. 74, n. 6, p. 817, doi. 10.1562/0031-8655(2001)0740817IVNFMA2.0.CO2
- By:
- Publication type:
- Article